Juliane Rauh
Overview
Explore the profile of Juliane Rauh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stiehler M, Rauh J, Bunger C, Jacobi A, Vater C, Schildberg T, et al.
Data Brief
. 2016 Aug;
8:545-8.
PMID: 27508214
This data article contains data related to the research article entitled, "in vitro characterization of bone marrow stromal cells from osteoarthritic donors" [1]. Osteoarthritis (OA) represents the main indication for...
2.
Stiehler M, Rauh J, Bunger C, Jacobi A, Vater C, Schildberg T, et al.
Stem Cell Res
. 2016 May;
16(3):782-9.
PMID: 27155399
BMSCs, also known as bone marrow-derived mesenchymal stem cells, provide an excellent source of progenitor cells for regenerative therapy. To assess whether osteoarthritis (OA) affects the regenerative potential of BMSCs...
3.
Lojewski X, Srimasorn S, Rauh J, Francke S, Wobus M, Taylor V, et al.
Stem Cells Transl Med
. 2015 Aug;
4(10):1223-33.
PMID: 26304036
Unlabelled: Brain perivascular cells have recently been identified as a novel mesodermal cell type in the human brain. These cells reside in the perivascular niche and were shown to have...
4.
Rauh J, Jacobi A, Stiehler M
Tissue Eng Part C Methods
. 2014 Jul;
21(2):192-206.
PMID: 25000821
The principles of tissue engineering (TE) are widely used for bone regeneration concepts. Three-dimensional (3D) cultivation of autologous human mesenchymal stromal cells (MSCs) on porous scaffolds is the basic prerequisite...
5.
Rauh J, Despang F, Baas J, Liebers C, Pruss A, Gelinsky M, et al.
Biomed Res Int
. 2014 Mar;
2014:784702.
PMID: 24678514
Bone transplantation is frequently used for the treatment of large osseous defects. The availability of autologous bone grafts as the current biological gold standard is limited and there is a...
6.
Schildberg T, Rauh J, Bretschneider H, Stiehler M
Stem Cell Res
. 2013 Oct;
11(3):1288-98.
PMID: 24080205
Bone marrow stromal cells (BMSCs) are key cellular components for musculoskeletal tissue engineering strategies. Furthermore, recent data suggest that BMSCs are involved in the development of Osteoarthritis (OA) being a...
7.
Jacobi A, Rauh J, Bernstein P, Liebers C, Zou X, Stiehler M
Biotechnol Prog
. 2013 May;
29(4):1034-42.
PMID: 23674393
Mesenchymal stromal cells (MSCs) are one of the most frequently used cell sources for tissue engineering strategies. Cultivation of osteogenic MSCs is a prerequisite for cell-based concepts that aim at...
8.
Rauh J, Milan F, Gunther K, Stiehler M
Tissue Eng Part B Rev
. 2011 Apr;
17(4):263-80.
PMID: 21495897
Bone graft material is often required for the treatment of osseous defects. However, due to limitations and risks associated with autologous as well as allogenic bone grafting procedures, alternative strategies...
9.
Stiehler M, Seib F, Rauh J, Goedecke A, Werner C, Bornhauser M, et al.
Cytotherapy
. 2010 May;
12(5):658-68.
PMID: 20429788
Background Aims: Combining autologous bone precursor cells with cancellous bone allograft (CBA) offers an appealing strategy for skeletal regeneration. In this context, multipotent mesenchymal stromal cells (MSC) provide an excellent...